Počet záznamů: 1  

In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity

  1. 1.
    SYSNO ASEP0450872
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevIn vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
    Tvůrce(i) Lynn, G. M. (US)
    Laga, Richard (UMCH-V) RID, ORCID
    Darrah, P. A. (US)
    Ishizuka, A. S. (US)
    Balaci, A. J. (US)
    Dulcey, A. E. (US)
    Pechar, Michal (UMCH-V) RID, ORCID
    Pola, Robert (UMCH-V) RID, ORCID
    Gerner, M. Y. (US)
    Yamamoto, A. (US)
    Buechler, C. R. (US)
    Quinn, K. M. (US)
    Smelkinson, M. G. (US)
    Vanek, O. (CZ)
    Cawood, R. (GB)
    Hills, T. (GB)
    Vasalatiy, O. (US)
    Kastenmüller, K. (US)
    Francica, J. R. (US)
    Stutts, L. (US)
    Tom, J. K. (US)
    Ah Ryu, K. (US)
    Esser-Kahn, A. P. (US)
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Fisher, K. D. (GB)
    Seymour, L. W. (GB)
    Seder, R. A. (US)
    Zdroj.dok.Nature Biotechnology. - : Nature Publishing Group - ISSN 1087-0156
    Roč. 33, č. 11 (2015), s. 1201-1210
    Poč.str.10 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovaadjuvants ; biomedical engineering ; drug delivery
    Vědní obor RIVCE - Biochemie
    CEPEE2.3.30.0029 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaUMCH-V - RVO:61389013
    UT WOS000364916000028
    EID SCOPUS84946572121
    DOI10.1038/nbt.3371
    AnotaceThe efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer–TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer–TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer–TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer–TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.
    PracovištěÚstav makromolekulární chemie
    KontaktEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Rok sběru2016
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.